OncoCyte Corp (OCX)

[capital gain]

76 percent of the shares are owned by Biotime, and they are not for sale. With an OS of 32 mil shares, that leaves only 7.7 million shares available to trade, as the recent 8 million shares from the placement are restricted for sale. A whiff of volume and this thing will fly.

Huge drop from over 6 Dollar 3 months ago, no doubt the people buying into this placement of shares were responsible for some of that, to push the share price to just under the placement price of $1.26, hence why it rebounded so violently the day after the placement was confirmed.
Still lots of room for this thing to move 50 Day MA is a $3.03 the next one the 200 day MA is all the way up at $4.76.

I reckon it will go through the 50 Day MA very easily on the way to the 200 Day MA.